NASDAQ
Global Pharmatech, Inc. (GBLP) has a price/sales ratio of 198.76x as of Friday, May 22, 2026. This represents a 66.87% decrease compared to its 12-month average of 599.89x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.